It also helps protect our mitochondria, is a cofactor for many enzymes in the body, and is vital to energy production
Despite these advantages, translating nanovaccine technologies into clinical use still faces several challenges, including large-scale production, long-term stability, regulatory approval, and the management of potential toxicity or immunogenic side effects
Transfection of complementary DNAs for the heavy and light subunits of human -glutamylcysteine synthetase results in an elevation of intracellular glutathione and resistance to melphalan
Development of interventions targeting amyloid beta plaques and tau protein tangles also have not been successful [8, 9], and the number of phase 3 trials focused on amyloid intervention has decreased since 2019 [10]
Is reactive oxygen species production elevated